Zydelig

Failing to confirm clinical benefit, Gilead pulls 2 accelerated approval indications for cancer drug
Endpoints
Fri, 01/21/22 - 11:07 am
Gilead Sciences
Zydelig
follicular B-cell non-Hodgkin lymphoma
small lymphocytic leukemia
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
How Gilead's blood cancer med Zydelig might also address triple-negative breast cancer
Fierce Biotech
Thu, 03/12/20 - 10:51 am
Gilead Sciences
Zydelig
breast cancer
triple negative breast cancer
Gilead Cancer Business Loses Top Exec Prior to Study Halts
TheStreet.com
Thu, 03/17/16 - 09:48 am
Gilead Sciences
clinical trials
Zydelig
As EMA investigates, Gilead halts six clinical trials of cancer drug
BioPharma Dive
Wed, 03/16/16 - 10:13 am
Gilead Sciences
Europe
clinical trials
Zydelig
Gilead Cancer Drug Reviewed After Deaths in Combo Trials
Bloomberg
Mon, 03/14/16 - 10:10 am
Gilead Sciences
clinical trials
Zydelig
Will This Study Finally Catapult Gilead Sciences Into a Cancer Powerhouse?
Motley Fool
Thu, 12/10/15 - 10:39 am
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
Can new PhIII data help Gilead's Zydelig stage a comeback in CLL?
Fierce Pharma Marketing
Wed, 12/9/15 - 11:36 am
Gilead Sciences
Zydelig
chronic lymphocytic leukemia
CLL
The 3 Most Important Drugs in Gilead Sciences' Pipeline
Motley Fool
Mon, 12/7/15 - 10:53 am
Gilead Sciences
simtuzumab
Zydelig
Sovaldi + velpatasvir
There's a 0.0000000000028% Chance This Drug Doesn't Work
Motley Fool
Tue, 12/1/15 - 10:12 am
Gilead Sciences
Zydelig
chronic lymphocytic leukemia
U.K. cost gatekeeper gives thumbs-up to Gilead's Zydelig for CLL
Fierce Pharma
Thu, 09/24/15 - 11:50 am
UK
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
Did Gilead Sciences Just Give Wall Street a Huge Head Fake?
Motley Fool
Sun, 08/9/15 - 11:21 am
Gilead Sciences
Zydelig
blood cancer
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Mon, 10/6/14 - 07:42 am
Gilead Sciences
Sovaldi
Harvoni
Zydelig
Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Mon, 09/22/14 - 08:37 am
Gilead Sciences
JNJ
Pharmacyclics
Imbruvica
Zydelig
Can Gilead break into cancer? With Zydelig approval, it gets its chance
Fierce Pharma
Fri, 07/25/14 - 09:16 am
Gilead Sciences
Zydelig
PI3k inhibitor
Roche
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
FDA
Zydelig
Gilead Sciences
chronic lymphocytic leukemia
follicular lymphoma
small lymphocytic lymphoma